Cite
HARVARD Citation
Yin, W. et al. (2021). Safety, pharmacokinetics and pharmacodynamics of TAK‐418, a novel inhibitor of the epigenetic modulator lysine‐specific demethylase 1A. British journal of clinical pharmacology. 87 (12), pp. 4756-4768. [Online].